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Abstract
Vibrio cholerae colonizes the small intestine of adult C57BL/6 mice. In this study, the physical and genetic parameters that
facilitate this colonization were investigated. Successful colonization was found to depend upon anesthesia with ketamine-
xylazine and neutralization of stomach acid with sodium bicarbonate, but not streptomycin treatment. A variety of common
mouse strains were colonized by O1, O139, and non-O1/non-O139 strains. All combinations of mutants in the genes for
hemolysin, the multifunctional, autoprocessing RTX toxin (MARTX), and hemagglutinin/protease were assessed, and it was
found that hemolysin and MARTX are each sufficient for colonization after a low dose infection. Overall, this study suggests
that, after intragastric inoculation, V. cholerae encounters barriers to infection including an acidic environment and an
immediate immune response that is circumvented by sodium bicarbonate and the anti-inflammatory effects of ketamine-
xylazine. After initial adherence in the small intestine, the bacteria are subjected to additional clearance mechanisms that
are evaded by the independent toxic action of hemolysin or MARTX. Once colonization is established, it is suggested that, in
humans, these now persisting bacteria initiate synthesis of the major virulence factors to cause cholera disease. This adult
mouse model of intestinal V. cholerae infection, now well-characterized and fully optimized, should serve as a valuable tool
for studies of pathogenesis and testing vaccine efficacy.
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Introduction
Innate immune defense against intestinal pathogens includes
physical barriers, circulating factors, release of reactive oxygen
species (ROS), and phagocytic cells. Evasion of these defenses by
bacteria is essential to establish colonization followed by growth
and expansion of the bacteria. Vibrio cholerae is a successful
pathogen of the small intestine leading to a profuse watery
diarrhea due to the action of cholera toxin (CT). The infectious
dose for V. cholerae is relatively high due to poor acid tolerance in
the stomach, the major physical barrier to V. cholerae infection [1].
Protective mechanisms by the bacteria against innate immunity in
the gut include lipopolysaccharide (LPS), which provides resis-
tance to complement [2], down-regulation of mannose-sensitive
hemagglutinin leading to protection from non-specific IgA [3],
formation of microcolonies within the crypts to protect from
phagocytosis [4], and the action of secreted cytotoxins [5].
Although much is known about pathogenesis, detailed studies of
the interaction of V. cholerae with the gut immune response
resulting in clearance and/or protection have been limited by the
lack of an animal model amenable to long-term colonization.
Recently, we observed that C57BL/6 mice are susceptible to V.
cholerae infection resulting in rapid lethality in a dose-dependent
manner [6]. This rapid death occurred independently of CT and
was due to the action of hemolysin (also known as V. cholerae
cytotoxin) with a secondary contribution by the multifunctional,
autoprocessing RTX toxin (MARTX) [6]. After low dose
infection, mice survived and V. cholerae routinely colonized the
small intestine and persisted for at least 72 hr. This ability to
establish prolonged colonization depended on secreted accessory
toxins as a multitoxin mutant strain deficient in production of CT
and accessory toxins hemolysin, MARTX, and hemagglutinin
(HA)/protease was cleared by 48 hr post-inoculation (p.i.) [5].
Although the accessory toxins play an important role in long-term
colonization, a multitoxin mutant strain was immunogenic such
that mice immunized with this strain were protected from
subsequent lethal challenge with wild-type V. cholerae [6]. These
studies established adult mice as a model system for study of V.
cholerae host-pathogen interactions and vaccine efficacy and
demonstrated a role for accessory toxins in cholera pathogenesis
and disease dissemination.
As this mouse model has many potential applications, we
revisited the development of the inoculation protocol to address
which physical and genetic parameters most influence successful
colonization of the mouse small intestine by V. cholerae. We find
that successful colonization depends on anesthesia with ketamine-
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bicarbonate, but not streptomycin treatment. Furthermore, we
find that hemolysin and MARTX are each sufficient to promote
prolonged colonization.
Materials and Methods
Bacterial strains and growth media
Bacterial strains used in this study are listed in Table 1. Internal
deletions in genes hlyA, hapA, rtxA, and lacZ were created as
previously described [7,8]. V. cholerae is routinely grown on L agar
plates with 100 mg/ml streptomycin and 50 mg/ml kanamycin as
appropriate. Bacterial cultures for mouse inoculations were grown
with shaking in L broth with antibiotics at 30uC to mid-log phase
(A600<0.5) or overnight (A600.6), washed with phosphate-
buffered saline (PBS), and adjusted to desired CFU/ml based on
the A600 determined using a Beckman Coulter DU530 spectro-
photometer to estimate culture density.
Mouse intestinal inoculations
Mouse inoculations were performed according to Northwestern
University IACUC approved protocols as previously described [5].
Briefly, specific pathogen free 4–5 week old C57BL/6, BALB/c,
C3H (Harlan, Indianapolis, IN) or CD-1 (Charles River
Laboratories, Wilmington, MA) were purchased and held in
barrier housing until inoculated. Mice were given 0.1% (w/v)
streptomycin for 4–7 days to ablate normal flora. 20–24 h prior to
inoculation, food was removed from cages to empty the stomach.
Mice were injected intraperitoneally with 60–70 mg/kg ketamine
and 12–14 mg/kg xylazine. When mice were deeply sedated,
50 ml of 8.5% (w/v) NaHCO3 was administered orally immedi-
ately followed by 50 ml of bacterial suspension. After inoculation,
mice were kept in microisolator cages with free access to food and
sterile water without streptomycin. The optimized ABL inocula-
tion protocol was performed as above except mice were not given
streptomycin or food restricted prior to anesthetization and
inoculation.
Assessment of bacterial colonization
At designated time points after inoculation, mice were
euthanized by cervical dislocation under anesthesia. The intestine
above the caecum was dissected, homogenized in PBS, and then
serially diluted in PBS for plate counts of recovered colony-
forming units (CFU). Mice for which fewer than 10 colonies were
recovered from 100 ml of undiluted homogenate (500 total CFU in
the small intestine) were recorded as non-colonized and plotted
below the detection limit line. Recovery of bacteria is reported as a
Colonization Index calculated as Col. Index=CFUrecovered/
CFUinoculated.
Statistical analysis
For statistical analysis, the Col. Index for non-colonizers was
determined using actual recovered CFU (499 or less) or 1 if 0
colonies were recovered. All data were analyzed by one of two
methods. A Kruskal-Wallis One Way ANOVA was performed to
determine if any groups in a data set were significantly different
followed by a Dunn’s Multiple Comparisons post-test to identify
significantly different groups. Identified groups were re-analyzed
using a one-tailed Mann Whitney non-parametric t-test to
compare medians. To determine if the frequency of survival or
colonization in a group was significant, a chi-square (x2) test was
performed comparing colonized vs cleared or surviving vs severely
moribund (euthanized) animals in the two groups. P values #0.05
were considered significant. Results of the Mann Whitney or x2
test are shown on figures as indicated in legend. All analyses were
performed using Prism 4 for Macintosh (Graphpad Software, Inc.,
La Jolla, CA).
Results
Treatment of mice with ketamine-xylazine and sodium
bicarbonate at time of inoculation are both necessary
and sufficient for efficient intestinal colonization of mice
Previous studies showed that mice are susceptible to small
intestine colonization with V. cholerae [5]. To better characterize oral
infection of adult mice, we initiated these studies by determining
which inoculation parameters facilitate successful colonization.
As a reference protocol based on previous experiments [5,6],
mouse inoculations were performed using streptomycin treatment
(S), food restriction (F), anesthesia with ketamine-xylazine (A),
neutralization of stomach acids with sodium bicarbonate (B), and
inoculation of V.choleraegrown to mid-log phase (L).Todetermine to
what extent each individual parameter contributes to colonization,
mice were separated into 6 groups and 5 groups were inoculated
with a high dose (125610
7 CFU) of El Tor O1 strain P27459 using
4 of the 5 parameters, while one control group was inoculated
utilizing all 5 inoculation parameters (+all).
Comparison of both survival rates and colonization 20 hr p.i.
showed that food restriction (SABL/-F), growth phase of bacteria
(SFAB/-L), and streptomycin pretreatment did not significantly
affect successful colonization or survival. Survival rates in these
groups were similar ranging from 60–83%, consistent with a dose
of 125610
7 as near the LD50 and median colonization indices
representing 10–200 fold growth (Fig. 1A). Although not
quantitatively different than use of an overnight culture of V.
cholerae, log phase growth was routinely used as the bacteria could
be quantified more accurately by spectrometry to standardize
inocula between different groups and experiments.
Table 1. Bacterial strains used in this study.
Category
Strain
Designation Relevant genotype
a Reference
Wild-type V. cholerae P27459 El Tor O1, Sm
R [23]
E7946 El Tor O1, Sm
R [23]
N16961 El Tor O1, Sm
R [8]
O395 Classical O1, Sm
R [23]
PL-21 O6 [24]
1322-69 O37 [25]
MO10 O139, Sm
R [26]
203-93 O141 [27]
P4 mutant series P4 P27459DctxAB::Km
R,S m
R [28]
KFV103 P4DhlyA [7]
KFV105 P4DrtxA [7]
KFV70 P4DhapA [7]
VOV3 P4DhlyADrtxA [6]
KFV102 P4DhlyADhapA [6]
KFV98 P4DrtxADhapA [6]
KFV101 P4DhlyADrtxADhapA [7]
aSm
R=streptomycin resistant, Km
R=kanamycin resistant.
doi:10.1371/journal.pone.0007352.t001
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mice survived to 20 hr and colonization was poor with only 2 of 9
mice colonized above the detection limit (Fig. 1A). In the group
that did not receive sodium bicarbonate (SFAL/-B), all the mice
also survived and colonization was significantly lower than in the
control group (p=0.04) (Fig. 1A). These data indicated that
anesthesia at the time of inoculation was the most significant factor
promoting colonization and sodium bicarbonate also had a
positive influence on colonization.
The previous experiment demonstrated parameters that were
necessary for efficient colonization. To determine if anesthesia and
bicarbonate treatment are sufficient to achieve colonization, one
reference group was anesthetized with ketamine-xylazine and
inoculated with sodium bicarbonate followed by log-phase bacteria
(ABL). Two additional groups were either only anesthetized (AL/-B)
or only treated with sodium bicarbonate (BL/-A). A third group was
anesthetized with isoflurane in place of ketamine-xylazine (BL(+I)).
The group that was both anesthetized with ketamine-xylazine and
treated with sodium bicarbonate (ABL) had 50% lethality and the
surviving mice were colonized at levels similar to mice treated with
all inoculation parameters (Fig. 1B). Miceinoculated with use of only
ketamine-xylazine or sodium bicarbonate showed significantly
reduced colonization leading to increased survival (Fig. 1B). These
data demonstrate that anesthesia with ketamine-xylazine and
sodium bicarbonate are both necessary and sufficient to achieve
high levels of early colonization of the small intestine. Surprisingly,
anesthesia with isoflurane could not substitute for ketamine-xylazine
(Fig. 1B). This result indicates that the positive effect of ketamine-
xylazine on colonization is not simply associated with sedation, but
rather is likely due to side effects of the drugs.
Figure 1. Inoculation strategy affects successful colonization of C57BL/6 mice. (A) Prior to inoculation, mice were treated as indicated on
the X axis (S-1 mg/ml streptomycin in water; F-restriction of food overnight; A-anesthesia with ketamine-xylazine intraperitoneally at time of
inoculation; B-intragastric delivery of sodium bicarbonate, and L-inoculation of bacteria in the logarithmic phase of growth. Control mice (+all) were
infected using all five parameters. Mice were then inoculated with 125610
7 CFU V. cholerae El Tor O1 strain P27459 and colonization of the small
intestine assessed after 20 hr. Data are pooled from 3 experiments so the input variation between experiments was normalized by dividing the
recovered CFU by the input CFU and data are thereby plotted as a log colonization index with dashed line at 0 indicating that CFU recovered was
identical to the input CFU (i). Markers above the dashed line are indicative of growth in the small intestine while markers below indicate clearance.
Values below the solid line (d.l.) were below the detection limit of 500 CFU in the small intestine. The number of mice that cleared V. cholerae from
the small intestine (n) over the total of mice in the group (nu) is also indicated. The experiment in panel B was performed as above except an
additional parameter of anesthesia with inhaled isoflurane (+I) was added and data are pooled from two experiments. Significant and borderline P
values are shown compared to control for survival (calculated by a x2 test) and for colonization (calculated by a Mann-Whitney non-parametric t-test
comparing medians).
doi:10.1371/journal.pone.0007352.g001
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of intestinal colonization
To determine whether intestinal infection with V. cholerae can be
studied in mice other than C57BL/6 mice, two inbred mouse
strains, BALB/c and C3H, and the outbred mouse strain CD-1
were inoculated using the ABL protocol with ,10
7 CFU El Tor
O1 strain P27459. All 3 strains of mice were colonized, indicating
that colonization is not restricted to one specific mouse strain
(Fig. 2A). BALB/c and C3H mice showed colonization indices 2
log units above the inoculum similar to observed colonization of
P27459 in C57BL/6 mice (Fig. 1B and 2B). By contrast bacterial
numbers recovered from CD-1 mice were significantly lower than
those from C57BL/6, BALB/c, and C3H mice (p=0.03). Thus,
the outbred CD-1 mice may have a reduced genetic susceptibility
to V. cholerae. However, it should be noted that, at the time of
inoculation, the age matched CD-1 mice had significantly higher
body weights (2560.9 g, p,0.001) compared to BALB/c and
C3H mice (16.760.7 g and 18.561.2 g, respectively). Thus, it is
possible the higher body weight of the CD-1 mice accounts for the
observed differences in colonization levels.
Both El Tor and some non-O1 V. cholerae strains can also
colonize the small intestine
As previous studies were limited to El Tor bacteria, it was
essential to determine if V. cholerae O1 of the Classical biotype or
from serogroups other than O1 can colonize the small intestine of
mice as well. C57BL/6 mice were inoculated using the ABL
protocol with ,10
7 CFU of O1 and non-O1 V. cholerae strains and
bacterial recovery was determined after 20 hr. As expected, El Tor
O1 strain P27459 colonized at high levels about 2 log units above
the inoculum. Other El Tor strains N16961 and E7946 also
colonized. By contrast, bacterial numbers recovered from mice
inoculated with Classical strain O395 were significantly lower
(p,=0.001) suggesting a severe defect in colonization (Fig. 2B).
Among non-O1 strains, the O139 strain MO10 was recovered
at levels similar to P27459 (Fig. 2B), the O141 strain similar to
E7946, and the O37 strain significantly lower at ,10-fold below
the inoculum (p=0.03). However, bacterial numbers from mice
inoculated with O6 were dramatically lower than P27459-
inoculated mice (p=0.002), colonizing with only low recovery of
bacteria similar to the Classical strain.
The reduced colonization in mice infected with the Classical
strain was pursued further. The infecting dose was increased and
both streptomycin-treated and non-treated mice were compared
(Fig. 2C). Although still below colonization levels normally
observed with El Tor strains and not significantly different from
controls, some mice inoculated with O395 (3/5) were colonized at
levels near the inoculum in streptomycin treated mice given a
higher dose. Thus, it is possible that any strain of V. cholerae can be
used in mouse inoculation studies, but the infective dose both in
the presence and absence of streptomycin must be first determined
empirically.
Colonization of mice inoculated with revised ABL
protocol is still dependent upon accessory toxins
In contrast to virulence and short-term colonization, experi-
ments of long-term colonization require low dose inoculum so that
the mice survive beyond 24 hr. Previously we showed that El Tor
O1 strain P27459 inoculated at low dose (10
5–10
6 CFU) could
persist in the small intestine at 2–3 log units below the inoculum
dose up to 72 hr without being cleared [5]. This ability to establish
persisting colonization did not depend on CT or toxin co-
regulated pili (TCP), but did depend on accessory toxins [5].
Figure 2. Effect of mouse and V. cholerae strain variation on
colonization. (A) Mouse strains as indicated were inoculated with
1.1610
7 CFU El Tor O1 strain P27459. (B) C57BL/6 mice were inoculated
with 0.521610
7 CFU of V. cholerae strain as indicated. (C) Streptomycin
treated and non-treated C57BL/6 mice were inoculated with either
223610
7 or 1.523.9610
8 CFU of V. cholerae Classical O395. All mice
were inoculated with the ABL strategy as described in the text and mice
were assessed for colonization of the small intestine 20 hr after
inoculation. Values are reported as a Col. Index as described in
Fig. legend 1. The number of mice that cleared V. cholerae from the
small intestine (n) over the total of mice in the group (nu) is also
indicated. Only statistically significant p values calculated by a Mann-
Whitney non-parametric t-test comparing medians are shown. P values
in panels A and B are compared to El Tor O1 P27459 infection in C57BL/
6 mice (Panel B) and in panel C to O395 control at 10
7 CFU.
doi:10.1371/journal.pone.0007352.g002
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protocol with CT deletion strain P4 remained colonized to 48 hr
after low dose infection, but none of the mice inoculated with
multitoxin deletion strain KFV101 (P4DhlyADrtxADhapA) remained
colonized (Fig. 3A and 3D, Mann-Whitney, p,0.001,
x
2=0.0006)). Thus, our revised inoculation protocol did not
change the requirement for accessory toxin genes to establish a
colonization that persists to 48 hr.
Colonization of mice depends on hemolysin and MARTX
To define which of the three individual accessory toxin(s) caused
the colonization defect of the multitoxin mutant strain KFV101,
colonization of the small intestine by P4 mutants deleted of a single
accessory toxin gene using the ABL inoculation strategy was
performed (Fig. 3B). Merged data from four experiments showed
that, contrary to consistent data wherein P4 colonizes and
KFV101 (P4DhlyADrtxADhapA) does not colonize, the deletion of
any single accessory toxin gene — hlyA, rtxA,o rhapA — from P4
reduced the overall colonizing frequency to 8/18 (44%, x
2,
p=0.0502), 6/14 (43%, x
2, p=0.0496), or 8/13 (62%, x
2,
p=0.211) mice, respectively, with the contributions of hlyA and
rtxA borderline for statistical significance. When the single
knockout strains did colonize, CFU recovered from the small
intestine of colonized mice was not significantly different from P4
(Mann-Whitney, p=0.26 to 0.48). Given results with single
mutants, it was not surprising that a mutant deleted of both hlyA
and rtxA was significantly defective for colonization (Mann-
Whitney, p=0.005; x
2, p=0.030) further identifying hlyA and
rtxA as the accessory toxins that promote colonization (Fig. 3C). By
contrast, deletion of hapA from either the P4DrtxA or P4DhlyA
strain did not further reduce colonization. Indeed, the loss of HA/
protease slightly increased colonization, although the data are not
significantly different from isogenic single mutants (Mann-
Whitney, p=0.18 to 0.40). These data indicated that none of
the accessory toxin genes are absolutely essential for colonization,
although hemolysin and MARTX significantly increase the
number of mice successfully colonized. In the P4 strain that
expresses all three toxins, the combined contribution of hemolysin
and MARTX is sufficient to overcome a minor antagonistic effect
from HA/protease.
Discussion
At the outset of this study, we sought to define both the physical
and genetic parameters that facilitate colonization of mice with V.
cholerae so that the model can be used both for basic science
investigation and vaccine development. One factor leading to
successful colonization of adult mice was the administration of
sodium bicarbonate to neutralize stomach acid. Surprisingly, the
most prominent factor was the use of ketamine-xylazine as the
anesthetic during inoculation. Ketamine and xylazine have many
pharmacological side effects, including an influence on intestinal
motility in large animals [9,10]. However, studies in rats have
shown that intestinal motility is not affected by ketamine [11]. The
positive effect of ketamine-xylazine in mice may therefore be
related to additional side effects of the drugs. It has been shown
that ketamine alone, or in combination with xylazine, inhibits the
host response to LPS leading to development of shock [12,13].
Specifically, ketamine attenuates LPS-induced TNFa expression
in the gastric mucosa and serum and decreases iNOS production
throughout the intestine, particular the small intestine. TNFa in
serum and the gastric mucosa return to basal level within 3 hr
after injection of LPS [12,13]. TNFa and iNOS are linked to
innate immune responses including release of antimicrobial
peptides and ROS. In the context of a bacterial infection, we
propose that use of ketamine during inoculation facilitates initial
colonization of the small intestine by inhibiting killing of the
bacteria shortly after intragastric inoculation. In fact, a study
performed in 1975 demonstrated that V. cholerae administered to
mice orally was killed in the small intestine within 2 hr after
inoculation [14]. Thus, ketamine may induce a transient
immunodeficiency for about 3 hr, that in the case of V. cholerae,
is absolutely essential for mice to be susceptible to small intestine
colonization. Without ketamine, .10
9 CFU V. cholerae and prior
treatment with streptomycin were required to colonize mice; but
even then, the bacteria predominantly localized to the large bowel
[15], rather than the small intestine as seen in ketamine-treated
mice [5].
The genetics of the bacterial and mouse strains also dramat-
ically affected successful colonization. Among wild-type strains
tested, El Tor O1 and O139 successfully colonized to 20 hr,
suggesting these strains with pandemic potential are most suited
for these types of studies although some non-O1/non-O139 strains
colonized as well. By contrast, a Classical O1 strain poorly
colonized and likely will require a high dose and streptomycin
treatment for successful infection. It is known that Classical strains
do not express a fully functional hemolysin [16], MARTX [17] or
HA/protease [18]. Similarly, PCR analysis revealed the poorly
colonizing O6 strain did not have an hlyA gene (data not shown).
Thus, the absence of accessory toxins may account for reduced
colonization by these strains. With regard to genetics of the mice,
the outbred mouse strain CD-1 was less susceptible to coloniza-
tion, however, it is possible this reflected the size of the mice rather
Figure 3. Colonization of the small intestine depends on
accessory toxins. Data represent merged results from 4 experiments,
wherein C57BL/6 mice were inoculated by the ABL strategy with a low
dose between 4610
5 to 4610
6 CFU and colonization of the small
intestine was assessed after 48 hr. Values are reported as a Col. Index as
described in Fig. legend 1. Despite variation in input, there was no
correlation between increased inoculum and improved colonization in
these data sets. The number of mice that cleared the infection over the
total mice in the experimental group is shown in the graph as number
cleared (n) over number inoculated nu. Number of mice varies since
single mutant knockout infections were repeated more often with more
mice per group to assure that observed differences in clearance
frequency initially observed were reproducible and not representative
of experiment to experiment variation or due to differences in the
inoculum.
doi:10.1371/journal.pone.0007352.g003
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bacterial strain and mouse strain might be used for these types of
studies, but the effective dose of the test strain in age-matched mice
will need to be routinely established.
Interestingly, among the accessory toxins, we found MARTX
and hemolysin in combination account for successful colonization
of El Tor O1 strains. Surprisingly, hemolysin and MARTX
affected the number of mice colonized, but not the level of bacteria
recovered from the small intestine of colonized mice. Thus, the
purpose of the accessory toxins could be to actively defend against
innate immune cells keeping the immune system suppressed
during early infection allowing time for the bacteria to replicate
and colonize. These toxins might function by directly targeting
phagocytic cells. Hemolysin has been shown to affect neutrophils,
while MARTX is known to cause actin crosslinking in macro-
phages [19,20]. Alternatively, these toxins could function by
targeting resident mast cells, macrophages and/or dendritic cells
blocking cytokine and chemokine release reducing the influx of
phagocytic cells that could aid in clearance of the bacteria.
In humans, it is predicted that the colonizing bacteria would
next progress to synthesis of the primary virulence factors CT and
TCP, resulting in the onset of cholera disease, generally 1–5 days
after exposure to the bacterium [21]. However, in most instances,
the bacteria would simply persist in the intestinal tract until cleared
5–10 days later by the acquired immune system, accounting for
the large number of asymptomatic carriers after V. cholerae
exposure [22].
Overall, our findings likely explain why other researchers have
not been able to successfully colonize adult mice with V. cholerae.
With the help of this defined model, one can now explore many
new hypotheses in V. cholerae-host interaction, such as studying
different genetic backgrounds and employing the various immu-
nological tools that are available for mice. In particular, this mouse
model will provide a means to test vaccine efficacy prior to human
clinical trials of oral live attenuated vaccines. A recent report used
oral challenge of vaccinated mice, but the challenge required a
high inoculom in streptomycin and isoflurane-treated mice
followed by monitoring CFU in stool for up to 17 days [15]. By
contrast, using ketamine-treated mice, we have demonstrated that
oral introduction of a live attenuated strain of V. cholerae induces
protection from a lethal dose of V. cholerae [6], a much more
convincing monitor of successful mucosal immunity.
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